Back

Efficacy of flecainide in patients with premature ventricular contractions-induced cardiomyopathy: Subanalysis of the UNIFLECA study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Holistic management of patients with premature ventricular contractions Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sotirios Kotoulas

Asklepieion Voulas General Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Flecainide efficacy in outflow tract vs non-outflow tract premature ventricular contractions: A subanalysis of the UNIFLECA study
Doctor M. Botis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
A comparative analysis of the safety of ventricular arrhythmia ablation in patients undergoing procedures for ventricular tachycardia and premature ventricular contractions.
Doctor N. Rafeenko (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Local activation time guided versus anatomical approach for ablation of premature ventricular complexes originating from the cardiac base
Doctor N. Tsianakas (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of premature ventricular complexes originating from papillary muscles using dual-energy lattice-tip focal catheter
Doctor F. Schlosser (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Athletes with premature ventricular beats: correlation with cardiac MRI findings and validation of risk stratification algorithms outside tertiary sports cardiology screening centers
Doctor A. Damele (Genova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Holistic management of patients with premature ventricular contractions

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Flecainide in the treatment of high premature ventricular contractions burden: preliminary results from the UNIFLECA study
thumbnail
Congress Presentation
Efficacy and safety of flecainide in patients with reduced ejection fraction and high premature ventricular complex burden: a single-center experience
thumbnail
Congress Presentation
Effect of flecainide on complex ventricular arrhythmogenesis: insights from the prospective UNIFLECA study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources